Papers
Topics
Authors
Recent
Search
2000 character limit reached

Extending Inferences from Randomized Clinical Trials to Target Populations: A Scoping Review of Transportability Methods

Published 11 Feb 2024 in stat.AP | (2402.07236v2)

Abstract: Objective: Randomized controlled trial (RCT) results often inform clinical decision-making, but the highly curated populations of trials and the care provided during the trial are often not reflective of real-world practice. The objective of this scoping review is to identify the ability of methods to transport findings from RCTs to target populations. Study design: A scoping review was conducted on the literature focusing on the transportability of the results from RCTs to observational cohorts. Each study was assessed based on the methodology used for transportability and the extent to which the treatment effect from the RCT was estimated in the target population in observational data. Results: A total of 15 published papers were included. The research topics include cardiovascular diseases, infectious diseases, psychiatry, oncology, orthopedics, anesthesiology, and hematology. These studies show that the findings from RCTs could be translated to real-world settings, with varying degrees of effect size and precision. In some cases, the estimated treatment effect for the target population were statistically significantly different from those in RCTs. Conclusion: Despite variations in the magnitude of effects between RCTs and real-world studies, transportability methods play an important role in effectively bridging the RCTs and real-world care delivery, offering valuable insights for evidence-based medicine.

Summary

Paper to Video (Beta)

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 0 likes about this paper.